1. The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies
- Author
-
Jaya Sangodkar, Rita Tohme, Sam Moody, Matthew D. Galsky, Analisa DiFeo, Marwan K. Tayeh, B. Mark Evers, Fallon K. Noto, Caitlin M. O’Connor, Bisoye Towobola Adedeji, Ming Tong, Tseten Yeshi Jamling, Kajari Bhattacharya, Lauren Hurst, Goutham Narla, Sudeh Izadmehr, Jyothsna Narla, Eric M. Ostertag, Amit R. Rupani, Christopher B. McClain, Xiaohua Gao, Jack Crawford, Jeffrey W. Innis, Erika Hanson, and Kristin LeSueur
- Subjects
0301 basic medicine ,Oncology ,Lung Neoplasms ,Rodent ,Colorectal cancer ,Physiology ,NK cells ,Lung and Intrathoracic Tumors ,Rats, Sprague-Dawley ,Prostate cancer ,0302 clinical medicine ,Carcinoma, Non-Small-Cell Lung ,Immune Physiology ,Cellular types ,Medicine and Health Sciences ,Multidisciplinary ,biology ,Prostate Cancer ,Immune cells ,Prostate Diseases ,Animal Models ,medicine.anatomical_structure ,Experimental Organism Systems ,030220 oncology & carcinogenesis ,Experimental pathology ,Medicine ,White blood cells ,Interleukin Receptor Common gamma Subunit ,Research Article ,medicine.medical_specialty ,Cell biology ,Blood cells ,Science ,Urology ,Immunology ,Spleen ,Mouse Models ,Research and Analysis Methods ,03 medical and health sciences ,Model Organisms ,Malignant Tumors ,RAG2 ,biology.animal ,Internal medicine ,Cell Line, Tumor ,medicine ,Carcinoma ,Animals ,Humans ,Colorectal Cancer ,Biology and life sciences ,Cancers and Neoplasms ,Neoplasms, Experimental ,medicine.disease ,Xenograft Model Antitumor Assays ,Rats ,Non-Small Cell Lung Cancer ,Genitourinary Tract Tumors ,030104 developmental biology ,Animal cells ,Cell culture ,Animal Studies ,Gene Deletion - Abstract
We have created the immunodeficient SRG rat, a Sprague-Dawley Rag2/Il2rg double knockout that lacks mature B cells, T cells, and circulating NK cells. This model has been tested and validated for use in oncology (SRG OncoRat®). The SRG rat demonstrates efficient tumor take rates and growth kinetics with different human cancer cell lines and PDXs. Although multiple immunodeficient rodent strains are available, some important human cancer cell lines exhibit poor tumor growth and high variability in those models. The VCaP prostate cancer model is one such cell line that engrafts unreliably and grows irregularly in existing models but displays over 90% engraftment rate in the SRG rat with uniform growth kinetics. Since rats can support much larger tumors than mice, the SRG rat is an attractive host for PDX establishment. Surgically resected NSCLC tissue from nine patients were implanted in SRG rats, seven of which engrafted and grew for an overall success rate of 78%. These developed into a large tumor volume, over 20,000 mm3 in the first passage, which would provide an ample source of tissue for characterization and/or subsequent passage into NSG mice for drug efficacy studies. Molecular characterization and histological analyses were performed for three PDX lines and showed high concordance between passages 1, 2 and 3 (P1, P2, P3), and the original patient sample. Our data suggest the SRG OncoRat is a valuable tool for establishing PDX banks and thus serves as an alternative to current PDX mouse models hindered by low engraftment rates, slow tumor growth kinetics, and multiple passages to develop adequate tissue banks.
- Published
- 2020